The outcomes of ECOG-7208 in 2nd line mCRC

The outcomes of ECOG-7208 in 2nd line mCRC

obr

1 year
48 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Howard Hochster, MD, explains the outcomes of the ECOG-7208 study in 2nd line metastatic colorectal cancer (mCRC) patients at Annual Meeting 2018.
Up Next Autoplay